Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

High androgen levels cause skin issues in PCOS, affecting quality of life.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

PCOS has no cure, but treatments can manage symptoms and improve health.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Spironolactone can reduce hair growth in women with hirsutism.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.